Range
3.55 - 3.69
Vol / Avg.
299.8K/1.1M
Div / Yield
-
52 Wk
0.65 - 8.78
Mkt Cap
102.4M
Payout Ratio
-
Open
3.65
P/E
-
EPS
-0.2
Shares
28.4M
Outstanding
28.4M
Total Float
27.9M
load more
Sector: Health Care.Industry: Biotechnology
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.190-0.200 -0.0100
REV0
Q4 2020Est.ActualSurprise
EPS-0.200
REV0

Related Companies

TickerCompanyChg %Mkt Cap
MBRXMoleculin Biotech0.28%102.4M

Moleculin Biotech Frequently Asked Questions

Q

How do I buy Moleculin Biotech (MBRX) stock?

A

You can purchase shares of Moleculin Biotech (NASDAQ: MBRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Moleculin Biotech's (MBRX) competitors?

Q

What is the target price for Moleculin Biotech (MBRX) stock?

A

There is no analysis for Moleculin Biotech

Q

Current Stock Price for Moleculin Biotech (MBRX)?

A

The stock price for Moleculin Biotech (NASDAQ: MBRX) is $3.6 last updated Today at 8:00:03 PM.

Q

Does Moleculin Biotech (MBRX) pay a dividend?

A

There are no upcoming dividends for Moleculin Biotech.

Q

When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?

A
Moleculin Biotech’s Q2 earnings are confirmed for after-market on August 11, 2021.
Q

Is Moleculin Biotech (MBRX) going to split?

A

There is no upcoming split for Moleculin Biotech.

Q

What sector and industry does Moleculin Biotech (MBRX) operate in?

A

Moleculin Biotech is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.